Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Glickman currently holds 37,887 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Glickman has been a net seller of NRBO stock. They have purchased $92.0K and sold $1.6M worth of shares.
Mark A. Glickman's most recent insider trade was on Jun 30, 2025, when they sold 28,147 shares at $0.00 per share.
Mark A. Glickman serves as Executive at NeuroBo Pharmaceuticals, Inc. (NRBO). They have executed 34 insider transactions totaling $1.7M over their tenure at the company.
Mark A. Glickman holds the position of Executive at NeuroBo Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Mark A. Glickman has shown a selling trading pattern, with $92.0K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark A. Glickman was on Nov 20, 2014, when they sold $1.4M worth of AUXL shares. This transaction involved 40,750 shares at $33.16 per share.
Mark A. Glickman currently owns 37,887 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Glickman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Glickman has 34 Form 4 filings on record as an insider at NeuroBo Pharmaceuticals, Inc..
Set alerts for Mark A. Glickman and 40,000+ other insiders.